Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration
Bidragets beskrivning
The delivery of therapeutic agents to the central nervous system remains a major challenge. This is especially true in neurodegenerative diseases. While significant discoveries have recently been made in the genetics of ALS/FTD, patients still have no real therapeutic treatments. Here we aim to boost the clinical translation of the preclinical research and assembled a multidisciplinary research team with complimentary expertise to (1) generate 3D in vitro multicellular organoid models from iPSCs derived from healthy and patients with ALS/FTD; (2) fully characterize the newly generated models using established assays in the consortium (e.g. molecular markers and electrophysiology); (3) explore mechanistic pathways in particular pro-inflammatory, anti-oxidant and DNA damage pathways and ultimately use the model for (4) drug and gene based therapeutic screening.
Visa merStartår
2020
Slutår
2023
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Kansainvälinen yhteisrahoitteinen ohjelma
Övriga uppgifter
Finansieringsbeslutets nummer
334801
Vetenskapsområden
Neurovetenskaper
Forskningsområden
Neurotiede
Identifierade teman
brain, neuroscience